Min Zhang,Chengqi Wang,Thomas D Otto,Jenna Oberstaller,Xiangyun Liao,Swamy R Adapa,Kenneth Udenze,Iraad F Bronner,Deborah Casandra,Matthew Mayho,Jacqueline Brown,Suzanne Li,Justin Swanson,Julian C Rayner,Rays H Y Jiang,John H Adams,Thomas D. Otto,Swamy R. Adapa,Iraad F. Bronner,Julian C. Rayner,Rays H. Y. Jiang,John H. Adams

Abstract:Saturating malaria mutagenesis Malaria is caused by eukaryotic Plasmodium spp. parasites that classically infect red blood cells. These are difficult organisms to investigate genetically because of their AT-rich genomes. Zhang et al. have exploited this peculiarity by using piggyBac transposon insertion sites to achieve saturation-level mutagenesis for identifying and ranking essential genes and drug targets (see the Perspective by White and Rathod). Genes that are current candidates for drug targets were identified as essential, in contrast to many vaccine target genes. Notably, the proteasome degradation pathway was confirmed as a target for developing therapeutic interventions because of the several essential genes involved and the link to the mechanism of action of the current frontline drug, artemisinin. Science , this issue p. eaap7847 ; see also p. 490

Uncovering the essential genes of the human malaria parasite Plasmodium falciparum by saturation mutagenesis